Clinical Endocannabinoid Deficiency: What is it and how does it manifest?
Medical cannabis, especially CBD cannabis varieties, has been gaining increasing popularity in recent years. This is primarily due to its wide range of potential therapeutic effects, which are now receiving significant attention from doctors and many other experts and researchers. We would all like to hear that medical cannabis can cure all of our ailments.
Although it is not a "cure-all", but rather a supportive or complementary method of standard treatment, it could indeed help with one specific health complication. In today's article, we will discuss the symptoms and consequences of clinical endocannabinoid deficiency. Let's dive in...
Endocannabinoid System and Its Functions
In many previous articles on our blog, we have already mentioned the endocannabinoid system and its importance. Today, we will look at this mechanism in great detail. Understanding it is absolutely crucial for delving into this issue.
When a person decides to incorporate medical or CBD cannabis into their life, they usually do so to achieve a specific goal in treating their difficulties. Whether it's relief from chronic or acute pain, nausea, headaches, skin problems, or consequences of neurodegenerative diseases, which include Alzheimer's and Parkinson's disease.
Medical cannabis can help with the above-mentioned diseases thanks to specific natural chemical compounds called cannabinoids. These are found in every cannabis plant and are responsible for all the properties and capabilities of cannabis that can be used in medicine. There are over 100 different cannabinoids, but the most well-known include THC, CBD, and CBG. Cannabinoid compounds bind and interact with a dense network of receptors, specifically CB1 and CB2 receptors, which are part of an extensive system known as the "endocannabinoid system", or ECS for short.
(Note: This is a partial translation due to character limits. Would you like me to continue with the rest of the text?)